EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of miR‐301a‐3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC

Baiyang Fu iD, Yuan Yao, Wenlong Liang iD, Yao Wang, Xi Chen iD, Jianguo Zhang iD

The Breast Journal · 2026

DOI: 10.1155/tbj/9941495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Breast Journal, 2026. Verfasst von Baiyang Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Harbin 150000, China, hrbmush.edu.cn. Hauptthemen laut MEDLINE: MicroRNAs, Ferroptosis, Triple Negative Breast Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Harbin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The current treatment of triple‐negative breast cancer (TNBC) remains challenging; however, regulating ferroptosis through miRNAs offers new insights for TNBC treatment strategies.

Methods

Bioinformatics methods were used to screen ferroptosis‐related differentially expressed genes (FRDEGs) in TNBC, and ferroptosis‐related miRNAs were screened by combining gene‐miRNA interaction network, miRNA survival analysis, and expression validation in clinical specimens. A nomogram was constructed to evaluate the prognostic impact of miR‐301a‐3p in TNBC. Cell proliferation and migration capabilities were assessed using the CCK‐8 assay, colony formation assay, and wound healing assay, respectively. The intracellular protein expression of GPX4 was measured by Western blot, and fluorescent probes were used to detect intracellular ROS and Fe 2+ levels.

Results

This study used bioinformatics methods to screen five FRDEGs in TNBC, thereby identifying six core miRNAs that can regulate these genes. Among these, miR‐301a‐3p expression was significantly upregulated in tumor tissues compared to adjacent normal tissues and was associated with poor patient prognosis. Subsequently, an excellent prediction model was established using miR‐301a‐3p expression information and patient clinicopathological information. Functional analyses revealed that miR‐301a‐3p promoted TNBC cell proliferation and migration. In addition, the inhibition of cell proliferation activity by miR‐301a‐3p inhibitor could be reversed by Ferrostatin‐1, and miR‐301a‐3p inhibitor could inhibit the expression of GPX4 and promote the accumulation of intracellular ROS and Fe 2+ . The promotion of cell proliferation activity by miR‐301a‐3p mimic could be reversed by Erastin, and miR‐301a‐3p mimic could promote the expression of GPX4 and inhibit the accumulation of intracellular ROS and Fe 2+ .

Conclusion

In conclusion, this study provides evidence that inhibition of miR‐301a‐3p expression promotes ferroptosis in TNBC cells and produces a synergistic anti‐cancer effect with Erastin, providing a new target for future TNBC ferroptosis treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsFerroptosisTriple Negative Breast NeoplasmsHumansFemaleCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesCell MovementPiperazinesPrognosis

Stichwörter der Autor:innen

bioinformaticsferroptosismiR-301a-3ptriple-negative breast cancer

Substanzen

MicroRNAsMIRN301A microRNA, humanPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesPiperazineserastin

Autor:innen und Institutionen

  • Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Harbin 150000, China, hrbmush.edu.cn.
  • Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Harbin 150000, China, hrbmush.edu.cn.

ORCID-Profile: Baiyang Fu, Wenlong Liang, Xi Chen, Jianguo Zhang

Förderung

  • National Natural Science Foundation of China
  • Harbin Medical University

Zitieren

APA

Fu, B., Yao, Y., Liang, W., Wang, Y., Chen, X., & Zhang, J. (2026). Inhibition of miR‐301a‐3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC. The Breast Journal. https://doi.org/10.1155/tbj/9941495

Vancouver

Fu B, Yao Y, Liang W, Wang Y, Chen X, Zhang J. Inhibition of miR‐301a‐3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC. The Breast Journal. 2026. doi:10.1155/tbj/9941495

BibTeX
@article{Fu2026,
  author = {Fu, Baiyang and Yao, Yuan and Liang, Wenlong and Wang, Yao and Chen, Xi and Zhang, Jianguo},
  title = {Inhibition of miR‐301a‐3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC},
  journal = {The Breast Journal},
  year = {2026},
  doi = {10.1155/tbj/9941495}
}
Kostenlos starten →